Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 15 of 15 for “"Drug Efficiency"”.

  1. Design and Fabrication of Functional Materials in Biomedical Application

    … implants, catheters, sutures, grafts, and drug delivery systems. However, most of the currently available biomaterials are immunogenic and fibrogenic with compliance mismatch with the host tissue and often produce toxic byproducts at the implant site. Therefore, there is an unmet need for …

    rice Repository record for Design and Fabrication of Functional Materials in Biomedical Application (opens in a new tab)

  2. Biochemical studies of targeted and bimodal analogues of the natural anticancer compounds combretastatin A-4 and illudin M

    … mechanism of apoptosis induction. The proposed drug uptake was analysed using specific inhibitors to disable certain transporters/carriers. Changes in the shapes of cellular and sub-cellular components resulting from drug treatment were observed by light microscopy, immune-fluorescence …

    bayreuth Repository record for Biochemical studies of targeted and bimodal analogues of the natural anticancer compounds combretastatin A-4 and illudin M (opens in a new tab)

  3. Toward precision medicine with nanopore technology

    … the effect of genomic alterations on cancer drug efficiency and engineer devices to monitor these changes for therapeutic response prediction. Nanopore-based detection technology features devices containing a nanometer-scale pore embedded in a thin membrane that can be utilized for DNA …

    rowan Repository record for Toward precision medicine with nanopore technology (opens in a new tab)

  4. Optimisation of bioprinting protocols for improved tissue formation. A fight against gravity

    … or be used as tissue models for evaluation of drug efficiency or toxicity. The microfluidic-based bioprinter Biopixlar, enables complex tissue generation with high-precision cell positioning. Yet, this technology could benefit from further optimisation for improved tissue formation. This …

    chalmers Repository record for Optimisation of bioprinting protocols for improved tissue formation. A fight against gravity (opens in a new tab)

  5. Development of a benchmarking protocol for cancer nanomedicines and informed creation of a novel stealth nanomedicine for passive accumulation in solid tumors

    … of life is elusive. Active research in new drug delivery methods and treatment targets has shown promise in the reduction of side effects, improvement of drug efficiency, and ability to cure disease, particularly within the relatively new field of cancer nanotechnology. Cancer nanotechnology …

    jhu Repository record for Development of a benchmarking protocol for cancer nanomedicines and informed creation of a novel stealth nanomedicine for passive accumulation in solid tumors (opens in a new tab)

  6. Neutralizing antibodies and the biological response to interferon-beta therapy

    … (IFN-beta) was the first disease modifying drug to be approved for the treatment of multiple sclerosis (MS). IFN-beta reduces relapse rates, relapse severity as well as slows the progression of disease burden. However, neutralizing antibodies (NAbs) occur in a proportion of patients …

    ubc Repository record for Neutralizing antibodies and the biological response to interferon-beta therapy (opens in a new tab) Download PDF for Neutralizing antibodies and the biological response to interferon-beta therapy (opens in a new tab)

  7. Vacuum evaporation of pharmaceuticalmolecules for the creation of medicallyactive nanostructures with enhancedactivities

    … mixing of chemical solvents used during drug formulation. One of the aims of this dissertation was primarily addressing vacuum evaporation as a solvent free method to effect improvements in drug solubility and drug efficiency to better administration and finally enhance patient survival.. …

    cau-kiel Repository record for Vacuum evaporation of pharmaceuticalmolecules for the creation of medicallyactive nanostructures with enhancedactivities (opens in a new tab)

  8. Novel Approaches to the Design and Analysis of Bayesian Clinical Trials

    … and leveraged their strengths to help with drug benefit-risk assessment, facilitate adaptive platform trial design, and assist with patient focused decision making.The dissertation begins by proposing an innovative Bayesian Data Envelopment Analysis (DEA) framework to perform quantitative …

    ku Repository record for Novel Approaches to the Design and Analysis of Bayesian Clinical Trials (opens in a new tab)

  9. In vitro screening of Trametes versicolor and Acacia nilotica derivatives for antimalarial efficacy

    … early warning signs of resistance, new novel drug leads are needed to ensure the safety of the populations at risk. With resistance growing, the development of new antimalarials is still slow as a result of tedious and prolonged discovery pipelines. Traditionally, antimalarial drug discoveries …

    salford Download PDF for In vitro screening of Trametes versicolor and Acacia nilotica derivatives for antimalarial efficacy (opens in a new tab)

  10. One-carbon transfer reactions in Leishmania lipid metabolism

    … without flagella in the mammalian host. Current drug treatments face problems like toxicity and increasing resistance, and no safe vaccine is available. To facilitate new drug development, it is important to elucidate host-parasite interaction at the molecular level. As intracellular parasites, …

    ttu Repository record for One-carbon transfer reactions in Leishmania lipid metabolism (opens in a new tab)

  11. Study of amphotericin B molecular aggregation into different carrier systems

    The amphotericin B (AmB) is a drug of peculiar physicochemical features: being amphiphilic and amphoteric. These characteristics turn difficult the drug load into therapeutic systems. AmB is currently available in the market as micelles, liposomes and lipid complex for injection. The literature …

    brazil-ufrn Repository record for Study of amphotericin B molecular aggregation into different carrier systems (opens in a new tab)

  12. Inhibition of the Cystine-Glutamate Transporter SLC7A11 increases sensitivity to Platinum-based drugs in Non-Small Cell Lung Cancer

    … clinical challenge. Platinum-based chemotherapy drugs (cisplatin and carboplatin) are used as first-line treatments in non-small cell lung cancer (NSCLC), the predominant histological subtype of lung cancer. These drugs crosslink DNA to inhibit cell proliferation, but also produce intracellular …

    unsw Repository record for Inhibition of the Cystine-Glutamate Transporter SLC7A11 increases sensitivity to Platinum-based drugs in Non-Small Cell Lung Cancer (opens in a new tab)

  13. New dose estimation methods and their application in early drug discovery using intravenous, oral and inhaled routes of administration for new chemical entities

    … the next generation of innovative medicines. Drug discovery scientists are directly challenged with the task of trying to overcome the challenge of poorR&D productivity by improving the quality of new chemical entities progressing into drug development to reduce drug attrition. This project …

    strathclyde Repository record for New dose estimation methods and their application in early drug discovery using intravenous, oral and inhaled routes of administration for new chemical entities (opens in a new tab)

  14. Statistical Analysis, Modeling, and Algorithms for Pharmaceutical and Cancer Systems

    … the optimal doses of a pharmaceutical drugs, including dynamic initial points, an automatic process for outlier detection and an algorithm that develops a graphic user interface(GUI) program. The developed statistical procedure assists medical scientists by reducing their time in …

    usf Repository record for Statistical Analysis, Modeling, and Algorithms for Pharmaceutical and Cancer Systems (opens in a new tab)

  15. Study of genetic by environmental interactions at transcriptomic and genomic levels

    … population is responsible for the difference in drug efficiency on the treatment of several diseases. The development of high-throughput genomic and transcriptomics technologies has been providing rapid access to DNA and RNA information in humans and cattle. The access to this genetic …

    uiuc Repository record for Study of genetic by environmental interactions at transcriptomic and genomic levels (opens in a new tab)